The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
The electric automaker said most factories would hit a run rate of 10,000 of the mass-market vehicles a week by the end of the year, suggesting the company could be on the path to achieving profitability. The company did still report a wider loss than expected for the current quarter, but it said it burned through less cash than in the first quarter.
Narcan, the nasal spray that saved Demi Lovato from overdosing, is now available without a prescription in 49 states. Roger Crystal, MD, CEO of Opiant Pharmaceuticals and founder of the drug, was interviewed Thursday by Cheddar.
A recent survey by research firm Cohn & Wolfe found that 86 percent of Americans think companies should be socially and environmentally responsible. Burt's Bees is carbon-neutral certified and hasn't sent any waste to a landfill since 2010. Paula Alexander, Director of Sustainable Business at the company, tells Cheddar why it's important to work for a company that makes a difference.
Peter Loftus, Reporter at the Wall Street Journal, is skeptical of pharmaceutical companies touting lower drug prices. Merck may be cutting prices on medications, Loftus told Cheddar, but the ones affected represent a smaller percentage of the company's total sales.
Kevin Sabet, who co-founded a nonprofit called Smart Approaches To Marijuana, compares the current state of the cannabis industry to the early days of the tobacco business. Back then, he points out, "we had a relatively new industry that had a product that [had] been around for a long time, but that they started marketing and developing into something addictive."
